Literature DB >> 17557073

Assisted reproductive technology surveillance - United States, 2004.

Victoria Clay Wright1, Jeani Chang, Gary Jeng, Michael Chen, Maurizio Macaluso.   

Abstract

PROBLEM/CONDITION: In 1996, CDC initiated data collection regarding assisted reproductive technology (ART) procedures performed in the United States, as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102-493 [October 24, 1992]). ART includes fertility treatments in which both eggs and sperm are handled in the laboratory (i.e., in vitro fertilization and related procedures). Patients who undergo ART procedures are more likely to deliver multiple-birth infants than women who conceive naturally. Multiple births are associated with increased risk for mothers and infants (e.g., pregnancy complications, premature delivery, low-birthweight infants, and long-term disability among infants). REPORTING PERIOD COVERED: 2004. DESCRIPTION OF SYSTEM: In 2004, CDC contracted with a statistical survey research organization, Westat, Inc., to obtain data from ART medical centers in the United States. Westat, Inc., maintains CDC's web-based data collection system called the National ART Surveillance System.
RESULTS: In 2004, a total of 127,977 ART procedures were reported to CDC. These procedures resulted in 36,760 live-birth deliveries and 49,458 infants. Nationwide, 74% of ART procedures used freshly fertilized embryos from the patient's eggs, 15% used thawed embryos from the patient's eggs, 8% used freshly fertilized embryos from donor eggs, and 4% used thawed embryos from donor eggs. Overall, 42% of ART transfer procedures resulted in a pregnancy, and 34% resulted in a live-birth delivery (delivery of one or more live-born infants). The highest live-birth rates were observed among ART procedures that used freshly fertilized embryos from donor eggs (51%). The highest numbers of ART procedures were performed among residents of California (17,303), New York (11,123), Illinois (9,306), Massachusetts (8,906), and New Jersey (8,513). These five states also reported the highest number of infants conceived through ART. Of 49,458 infants born through ART, 50% were born in multiple-birth deliveries. The multiple-birth risk was highest for women who underwent ART transfer procedures that used freshly fertilized embryos from either donor eggs (40%) or their own eggs (33%). Approximately 1% of U.S. infants born in 2004 were conceived through ART. Those infants accounted for 18% of multiple births nationwide. Approximately 9% of ART singletons, 56% of ART twins, and 95% of ART triplets or higher-order multiples were low birthweight. The percentages of ART infants born preterm were 15% among singletons, 64% among twins, and 98% among triplets or higher-order multiples.
INTERPRETATION: Whether an ART procedure resulted in a pregnancy and live-birth delivery varied according to different patient and treatment factors. ART poses a major risk for multiple births. This risk varied according to the patient's age, the type of ART procedure performed, the number of embryos transferred, the day of embryo transfer (day 3 or day 5), and embryo availability. PUBLIC HEALTH ACTIONS: ART-related multiple births represent a sizable proportion of all multiple births nationwide and in selected states. To minimize the adverse maternal and child health effects that are associated with multiple pregnancies, ongoing efforts to limit the number of embryos transferred in each ART procedure should be continued and strengthened. Adverse maternal and infant outcomes (e.g., low birthweight and preterm delivery) associated with ART treatment choices should be explained fully when counseling patients who are considering ART.

Entities:  

Mesh:

Year:  2007        PMID: 17557073

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  20 in total

1.  Utilization of infertility treatments: the effects of insurance mandates.

Authors:  Marianne P Bitler; Lucie Schmidt
Journal:  Demography       Date:  2012-02

2.  Utilization of fertility-related services in the United States.

Authors:  Anjel Vahratian
Journal:  Fertil Steril       Date:  2008-03-04       Impact factor: 7.329

3.  Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.

Authors:  Rafal Kurzawa; Przemyslaw Ciepiela; Tomasz Baczkowski; Krzysztof Safranow; Pawel Brelik
Journal:  J Assist Reprod Genet       Date:  2008-09-19       Impact factor: 3.412

4.  Hematopoetic prostaglandin D synthase: an ESR1-dependent oviductal epithelial cell synthase.

Authors:  Phillip J Bridges; Myoungkun Jeoung; Sarah Shim; Ji Yeon Park; Jae Eun Lee; Lindsay A Sapsford; Kourtney Trudgen; Chemyong Ko; Myung Chan Gye; Misung Jo
Journal:  Endocrinology       Date:  2012-02-28       Impact factor: 4.736

5.  Identification of a novel role for endothelins within the oviduct.

Authors:  Myoungkun Jeoung; Sungeun Lee; Hee-Kyung Hawng; Yong-Pil Cheon; Youn Kyung Jeong; Myung Chan Gye; Marc Iglarz; Chemyong Ko; Phillip J Bridges
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

6.  Methodology matters: IVF versus ICSI and embryonic gene expression.

Authors:  Phillip J Bridges; Myoungkun Jeoung; Heyoung Kim; Jung Ho Kim; Dong Ryul Lee; CheMyong Ko; Doris J Baker
Journal:  Reprod Biomed Online       Date:  2011-05-08       Impact factor: 3.828

7.  A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve.

Authors:  Fethiye Sinem Karipcin; Amjad Hossain; John Y Phelps
Journal:  J Assist Reprod Genet       Date:  2011-09-13       Impact factor: 3.412

8.  Too old for IVF: are we discriminating against older women?

Authors:  Norbert Gleicher; Andrea Weghofer; David Barad
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

9.  The challenge of infant mortality: have we reached a plateau?

Authors:  Marian F MacDorman; T J Mathews
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

10.  Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.

Authors:  Norbert Gleicher; Eddy Ryan; Andrea Weghofer; Sonia Blanco-Mejia; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2009-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.